XML 49 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1

SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Dec. 31, 2023

Quarterly Financial Information Disclosure [Abstract]

SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

Restatement of Interim Financial Information (Unaudited)

Due to the misstatements described in Note 1 above, the Company has restated its unaudited condensed consolidated balance sheets, condensed consolidated statements of operations and comprehensive loss, condensed consolidated statements of convertible preferred stock and stockholders’ equity (deficit), and condensed consolidated statements of cash flows for the quarterly periods ended March 31, 2022, June 30, 2022, September 30, 2022, March 31, 2023, June 30, 2023 and September 30, 2023.

			March 31, 2023																		March 31, 2022
Corrected Condensed Consolidated Balance Sheets (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
ASSETS
Current assets:
Cash and cash equivalents			$	47,976					$	—					$	47,976					$	36,488					$	—					$	36,488
Restricted Cash			—						—						—						1,482						—						1,482
Accounts receivable			25,826						295						26,121						8,783						—						8,783
Prepaid expenses and other current assets			5,686						25						5,711						5,254						—						5,254
Total current assets			79,488						320						79,808						52,007						—						52,007
Property and equipment, net			270						—						270						239						—						239
Operating lease right-of-use asset			917						(81)						836						2,030						(184)						1,846
Other assets			1,061						—						1,061						1,019						—						1,019
Total assets			$	81,736					$	239					$	81,975					$	55,295					$	(184)					$	55,111
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable			3,980						46						4,026						2,861						—						2,861
Accrued liabilities			9,078						30						9,108						9,234						720						9,954
Accrued indirect tax liabilities			—						11,795						11,795						—						7,942						7,942
Accrued compensation and benefits			5,843						—						5,843						3,079						—						3,079
Current contract liabilities			15,761						29						15,790						14,260						—						14,260
Current portion of operating lease liability			1,001						(81)						920						1,190						(100)						1,090
Current portion of term loan			—						—						—						1,481						—						1,481
Total current liabilities			35,663						11,819						47,482						32,105						8,562						40,667
Long-term contract liabilities			19,236						150						19,386						17,229						—						17,229
Long-term operating lease liability			—						—						—						1,004						(84)						920
Total liabilities			54,899						11,969						66,868						50,338						8,478						58,816
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock (1)
Series X Convertible Preferred stock (2)			—						—						—						—						—						—
Common stock (3)			9						—						9						7						—						7
Additional paid-in capital			430,585						—						430,585						400,398						(720)						399,678
Accumulated deficit			(403,757)						(11,730)						(415,487)						(395,448)						(7,942)						(403,390)
Total stockholders’ equity (deficit)			26,837						(11,730)						15,107						4,957						(8,662)						(3,705)
Total liabilities and stockholders’ equity (deficit)			$	81,736					$	239					$	81,975					$	55,295					$	(184)					$	55,111
(1) Preferred stock, $0.0001 par value; 10,000,000 shares authorized at March 31, 2023 and March 31, 2022
(2) Series X Convertible Preferred Stock, $0.0001 par value; 4,947,759 shares authorized at March 31, 2023 and March 31, 2022; 2,156,713 shares issued and 2,104,472 shares outstanding at March 31, 2023; 1,870,713 shares issued and 1,818,472 shares outstanding at March 31, 2022
(3) Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2023 and March 31, 2022; 90,024,562 shares issued and outstanding at March 31, 2023 and 69,049,247 shares issued and outstanding at March 31, 2022

			June 30, 2023																		June 30, 2022
Corrected Condensed Consolidated Balance Sheets (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
ASSETS
Current assets:
Cash and cash equivalents			$	50,430					$	—					$	50,430					$	24,637					$	—					$	24,637
Restricted cash			—						—						—						370						—						370
Accounts receivable			5,483						—						5,483						4,833						—						4,833
Inventory			1,954						434						2,388						—						—						—
Prepaid expenses and other current assets			4,373						—						4,373						6,706						—						6,706
Total current assets			62,240						434						62,674						36,546						—						36,546
Property and equipment, net			297						—						297						201						—						201
Operating lease right-of-use asset			4,388						(81)						4,307						1,764						(162)						1,602
Other assets			1,061						—						1,061						1,013						—						1,013
Total assets			$	67,986					$	353					$	68,339					$	39,524					$	(162)					$	39,362
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable			1,899						—						1,899						3,091						—						3,091
Accrued liabilities			10,022						—						10,022						8,567						—						8,567
Accrued indirect tax liabilities			—						13,431						13,431						—						10,582						10,582
Accrued compensation and benefits			3,582						—						3,582						3,464						—						3,464
Current contract liabilities			14,975						—						14,975						14,730						—						14,730
Current portion of operating lease liability			942						(81)						861						1,233						(104)						1,129
Current portion of term loan			—						—						—						370						—						370
Total current liabilities			31,420						13,350						44,770						31,455						10,478						41,933
Long-term contract liabilities			17,551						—						17,551						15,351						—						15,351
Long-term operating lease liability			3,601						—						3,601						679						(58)						621
Total liabilities			52,572						13,350						65,922						47,485						10,420						57,905
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock (4)
Series X Convertible Preferred stock (5)			—						—						—						—						—						—
Common stock (6)			9						—						9						7						—						7
Additional paid-in capital			431,519						—						431,519						400,599						—						400,599
Accumulated deficit			(416,114)						(12,997)						(429,111)						(408,567)						(10,582)						(419,149)
Total stockholders’ equity (deficit)			15,414						(12,997)						2,417						(7,961)						(10,582)						(18,543)
Total liabilities and stockholders’ equity (deficit)			$	67,986					$	353					$	68,339					$	39,524					$	(162)					$	39,362
(4) Preferred stock, $0.0001 par value; 10,000,000 shares authorized at June 30, 2023 and June 30, 2022
(5) Series X Convertible Preferred Stock, $0.0001 par value; 4,947,759 shares authorized at June 30, 2023 and June 30, 2022; 2,156,713 shares issued and 2,104,472 shares outstanding at June 30, 2023; 1,870,713 shares issued and 1,818,472 shares outstanding at June 30, 2022
(6) Common stock, $0.0001 par value; 200,000,000 shares authorized at June 30, 2023 and June 30, 2022; 90,251,746 shares issued and outstanding at June 30, 2023 and 69,238,508 shares issued and outstanding at June 30, 2022

			September 30, 2023																		September 30, 2022
Corrected Condensed Consolidated Balance Sheets (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
ASSETS
Current assets:
Cash and cash equivalents			$	48,670					$	—					$	48,670					$	53,078					$	—					$	53,078
Accounts receivable			2,855						323						3,178						5,042						—						5,042
Inventory			2,467						434						2,901						—						—						—
Prepaid expenses and other current assets			3,712						—						3,712						5,779						—						5,779
Total current assets			57,704						757						58,461						63,899						—						63,899
Property and equipment, net			580						—						580						173						—						173
Operating lease right-of-use asset			4,131						(81)						4,050						1,491						(137)						1,354
Other assets			1,053						—						1,053						1,295						—						1,295
Total assets			$	63,468					$	676					$	64,144					$	66,858					$	(137)					$	66,721
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable			3,661						—						3,661						4,244						—						4,244
Accrued liabilities			11,772						—						11,772						8,162						—						8,162
Accrued indirect tax liabilities			—						14,689						14,689						—						11,314						11,314
Accrued compensation and benefits			4,457						—						4,457						4,117						—						4,117
Current contract liabilities			14,679						—						14,679						15,249						—						15,249
Current portion of operating lease liability			1,051						(81)						970						1,277						(108)						1,169
Total current liabilities			35,620						14,608						50,228						33,049						11,206						44,255
Long-term contract liabilities			16,504						—						16,504						24,398						—						24,398
Long-term operating lease liability			3,306						—						3,306						344						(29)						315
Total liabilities			55,430						14,608						70,038						57,791						11,177						68,968
Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock (7)
Series X Convertible Preferred stock (8)			—						—						—						—						—						—
Common stock (9)			9						—						9						7						—						7
Additional paid-in capital			432,315						—						432,315						402,649						—						402,649
Accumulated deficit			(424,286)						(13,932)						(438,218)						(393,589)						(11,314)						(404,903)
Total stockholders’ equity (deficit)			8,038						(13,932)						(5,894)						9,067						(11,314)						(2,247)
Total liabilities and stockholders’ equity (deficit)			$	63,468					$	676					$	64,144					$	66,858					$	(137)					$	66,721
(7) Preferred stock, $0.0001 par value; 10,000,000 shares authorized at September 30, 2023 and September 30, 2022
(8) Series X Convertible Preferred Stock, $0.0001 par value; 4,947,759 shares authorized at September 30, 2023 and September 30, 2022; 2,156,713 shares issued and 2,104,472 shares outstanding at September 30, 2023; 1,870,713 shares issued and 1,818,472 shares outstanding at September 30, 2022
(9) Common stock, $0.0001 par value; 200,000,000 shares authorized at September 30, 2023 and September 30, 2022; 90,415,944 shares issued and outstanding at September 30, 2023 and 71,181,197 shares issued and outstanding at September 30, 2022

			Three Months Ended March 31, 2023																		Three Months Ended March 31, 2022
Corrected Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Revenues:
Collaboration revenue			$	25,990					$	117					$	26,107					$	7,109					$	160					$	7,269
Total revenues			25,990						117						26,107						7,109						160						7,269
Operating expenses:
Research and development			18,715						154						18,869						20,166						215						20,381
General and administrative			4,298						159						4,457						5,204						138						5,342
Total operating expenses			23,013						313						23,326						25,370						353						25,723
Income (loss) from operations			2,977						(196)						2,781						(18,261)						(193)						(18,454)
Other income (expense), net:
Interest income (expense), net			232						—						232						(20)						—						(20)
Total other income (expense), net			232						—						232						(20)						—						(20)
Net income (loss) and comprehensive income (loss)			3,209						(196)						3,013						(18,281)						(193)						(18,474)
Allocation of earnings to participating securities			(677)						41						(636)						—						—						—
Net income (loss) attributable to common stockholders			$	2,532					$	(155)					$	2,377					$	(18,281)					$	(193)					$	(18,474)
Basic net earnings (loss) per common share (10)			$	0.03											$	0.03					$	(0.27)											$	(0.27)
Diluted net earnings (loss) per common share (10)			$	0.03											$	0.03					$	(0.27)											$	(0.27)
Shares used to compute basic net earnings (loss) per common share			78,640,086												78,640,086						68,138,116												68,138,116
Shares used to compute diluted net earnings (loss) per common share			101,189,396												101,189,396						68,138,116												68,138,116
(10) As the Company was in an income position for the three-months ended March 31, 2023, the two-class method was used to compute basic net earnings per share and the Company calculated diluted net earnings per share based on the more dilutive of (1) the treasury stock method, reverse treasury stock method or if-converted method, as applicable, or (2) the two-class method.

			Three Months Ended June 30, 2023																		Three Months Ended June 30, 2022
Corrected Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Revenues:
Collaboration revenue			$	7,614					$	(117)					$	7,497					$	6,216					$	—					$	6,216
Total revenues			7,614						(117)						7,497						6,216						—						6,216
Operating expenses:
Research and development			17,135						421						17,556						15,255						1,375						16,630
General and administrative			3,310						729						4,039						4,074						1,265						5,339
Total operating expenses			20,445						1,150						21,595						19,329						2,640						21,969
Loss from operations			(12,831)						(1,267)						(14,098)						(13,113)						(2,640)						(15,753)
Other income (expense), net:
Interest income (expense), net			623						—						623						(6)						—						(6)
Total other income (expense), net			623						—						623						(6)						—						(6)
Net loss before income tax expense			(12,208)						(1,267)						(13,475)						(13,119)						(2,640)						(15,759)
Income tax expense			(149)						—						(149)						—						—						—
Net loss and comprehensive loss			$	(12,357)					$	(1,267)					$	(13,624)					$	(13,119)					$	(2,640)					$	(15,759)
Basic and diluted net loss per common share			$	(0.14)											$	(0.15)					$	(0.19)											$	(0.23)
Shares used to compute basic and diluted net loss per common share			90,115,859												90,115,859						69,133,700												69,133,700

			Six Months Ended June 30, 2023																		Six Months Ended June 30, 2022
Corrected Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Revenues:
Collaboration revenue			$	33,604					$	—					$	33,604					$	13,325					$	160					$	13,485
Total revenues			33,604						—						33,604						13,325						160						13,485
Operating expenses:
Research and development			35,850						575						36,425						35,421						1,590						37,011
General and administrative			7,608						888						8,496						9,278						1,403						10,681
Total operating expenses			43,458						1,463						44,921						44,699						2,993						47,692
Loss from operations			(9,854)						(1,463)						(11,317)						(31,374)						(2,833)						(34,207)
Other income (expense), net:
Interest income (expense), net			855						—						855						(26)						—						(26)
Total other income (expense), net			855						—						855						(26)						—						(26)
Loss before income tax expense			(8,999)						(1,463)						(10,462)						(31,400)						(2,833)						(34,233)
Income tax expense			(149)						—						(149)						—						—						—
Net loss and comprehensive loss			$	(9,148)					$	(1,463)					$	(10,611)					$	(31,400)					$	(2,833)					$	(34,233)
Basic and diluted net loss per common share			$	(0.11)											$	(0.13)					$	(0.46)											$	(0.50)
Shares used to compute basic and diluted net loss per common share			84,409,667												84,409,667						68,638,651												68,638,651

			Three Months Ended September 30, 2023																		Three Months Ended September 30, 2022
Corrected Condensed Consolidated Statement of Operations and Comprehensive Income (Loss) (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Revenues:
Collaboration revenue			$	11,250					$	—					$	11,250					$	40,744					$	—					$	40,744
Product revenue			1,468						—						1,468						—						—						—
Total revenues			12,718						—						12,718						40,744						—						40,744
Operating expenses:
Cost of product revenue			387						—						387						—						—						—
Research and development			17,330						59						17,389						20,041						242						20,283
General and administrative			3,556						876						4,432						5,780						490						6,270
Total operating expenses			21,273						935						22,208						25,821						732						26,553
Income (loss) from operations			(8,555)						(935)						(9,490)						14,923						(732)						14,191
Other income, net:
Interest income, net			613						—						613						55						—						55
Total other income, net			613						—						613						55						—						55
Net income (loss) before income tax expense			(7,942)						(935)						(8,877)						14,978						(732)						14,246
Income tax expense			(230)						—						(230)						—						—						—
Net income (loss) and comprehensive income (loss)			(8,172)						(935)						(9,107)						14,978						(732)						14,246
Allocation of earnings to participating securities			—						—						—						(3,081)						150						(2,931)
Net income (loss) attributable to common stockholders			$	(8,172)					$	(935)					$	(9,107)					$	11,897					$	(582)					$	11,315
Basic net earnings (loss) per common share (11)			$	(0.09)											$	(0.10)					$	0.17											$	0.16
Diluted net earnings (loss) per common share (11)			$	(0.09)											$	(0.10)					$	0.17											$	0.16
Shares used to compute basic net earnings (loss) per common share			90,287,441												90,287,441						70,217,985												70,217,985
Shares used to compute diluted net earnings (loss) per common share			90,287,441												90,287,441						88,592,568												88,592,568
(11) As the Company was in an income position for the three-months ended September 30, 2022, the two-class method was used to compute basic net earnings per share and the Company calculated diluted net earnings per share based on the more dilutive of (1) the treasury stock method, reverse treasury stock method or if-converted method, as applicable, or (2) the two-class method.

			Nine Months Ended September 30, 2023																		Nine Months Ended September 30, 2022
Corrected Condensed Consolidated Statement of Operations and Comprehensive Loss (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Revenues:
Collaboration revenue			$	44,854					$	—					$	44,854					$	54,069					$	160					$	54,229
Product revenue			1,468						—						1,468						—						—						—
Total revenues			46,322						—						46,322						54,069						160						54,229
Operating expenses:
Cost of product revenue			387						—						387						—						—						—
Research and development			53,180						634						53,814						55,462						1,832						57,294
General and administrative			11,164						1,764						12,928						15,058						1,893						16,951
Total operating expenses			64,731						2,398						67,129						70,520						3,725						74,245
Loss from operations			(18,409)						(2,398)						(20,807)						(16,451)						(3,565)						(20,016)
Other income, net:
Interest income, net			1,468						—						1,468						29						—						29
Total other income, net			1,468						—						1,468						29						—						29
Net loss before income tax expense			(16,941)						(2,398)						(19,339)						(16,422)						(3,565)						(19,987)
Income tax expense			(379)						—						(379)						—						—						—
Net loss and comprehensive loss			$	(17,320)					$	(2,398)					$	(19,718)					$	(16,422)					$	(3,565)					$	(19,987)
Basic and diluted net loss per common share			$	(0.20)											$	(0.23)					$	(0.24)											$	(0.29)
Shares used to compute basic and diluted net loss per common share			86,390,446												86,390,446						69,170,865												69,170,865

			Three Months Ended March 31, 2023																		Three Months Ended March 31, 2022
Corrected Condensed Consolidated Statement of Cash Flows (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Operating activities:
Net income (loss)			$	3,209					$	(196)					$	3,013					$	(18,281)					$	(193)					$	(18,474)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			640						—						640						1,338						—						1,338
Non-cash operating lease expense			288						(26)						262						258						(24)						234
Depreciation and amortization			32						—						32						39						—						39
Amortization of costs to obtain a contract with a customer			475						—						475						—						—						—
Non-cash interest expense			—						—						—						1						—						1
Changes in assets and liabilities:
Accounts receivable			(19,993)						(295)						(20,288)						(3,427)						—						(3,427)
Prepaid expenses, other current assets, and other assets			872						(24)						848						(1,120)						—						(1,120)
Accounts payable and accrued liabilities			3,116						76						3,192						657						—						657
Accrued indirect tax liabilities			—						261						261						—						353						353
Accrued compensation and benefits			921						—						921						(1,953)						—						(1,953)
Contract liabilities			(142)						178						36						(844)						(160)						(1,004)
Operating lease liabilities			(316)						26						(290)						(276)						24						(252)
Net cash used in operating activities			(10,898)						—						(10,898)						(23,608)						—						(23,608)
Investing activities:
Purchases of property and equipment			(94)						—						(94)						(84)						—						(84)
Net cash used in investing activities			(94)						—						(94)						(84)						—						(84)
Financing activities:
Proceeds from underwritten public offering, net of issuance costs			17,593						—						17,593						—						—						—
Proceeds from public offering of common stock, net of issuance costs			8,630						—						8,630						500						—						500
Proceeds from exercise of stock options			14						—						14						—						—						—
Principal repayments of Term Loan			—						—						—						(1,111)						—						(1,111)
Net cash provided by (used in) financing activities			26,237						—						26,237						(611)						—						(611)
Net increase (decrease) in cash and cash equivalents			15,245						—						15,245						(24,303)						—						(24,303)
Cash and cash equivalents at beginning of period			32,731						—						32,731						62,273						—						62,273
Cash and cash equivalents at end of period			$	47,976					$	—					$	47,976					$	37,970					$	—					$	37,970
Supplemental disclosure of cash flows:
Interest paid			$	—					$	—					$	—					$	25					$	—					$	25
Non-cash investing activity:
Purchases of property and equipment, included in accounts payable and accrued liabilities			$	55					$	—					$	55					$	16					$	—					$	16
Non-cash financing activities:
Issuance costs incurred but not yet paid, included in accounts payable and accrued liabilities			$	337					$	—					$	337					$	—					$	720					$	720

			Six Months Ended June 30, 2023																		Six Months Ended June 30, 2022
Corrected Condensed Consolidated Statement of Cash Flows (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Operating activities:
Net loss			$	(9,148)					$	(1,463)					$	(10,611)					$	(31,400)					$	(2,833)					$	(34,233)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			1,435						—						1,435						2,016						—						2,016
Non-cash operating lease expense			664						(25)						639						523						(47)						476
Depreciation and amortization			57						—						57						77						—						77
Amortization of costs to obtain a contract with a customer			40						—						40						—						—						—
Non-cash interest expense			—						—						—						1						—						1
Changes in assets and liabilities:
Accounts receivable			350						—						350						524						—						524
Inventory			(1,954)						(434)						(2,388)						—						—						—
Prepaid expenses, other current assets, and other assets			2,120						—						2,120						(2,567)						—						(2,567)
Accounts payable and accrued liabilities			2,870						—						2,870						(483)						—						(483)
Accrued indirect tax liabilities			—						1,897						1,897						—						2,993						2,993
Accrued compensation and benefits			(1,277)						—						(1,277)						(1,324)						—						(1,324)
Contract liabilities			(2,613)						—						(2,613)						(2,252)						(160)						(2,412)
Operating lease liabilities			(620)						25						(595)						(559)						47						(512)
Net cash used in operating activities			(8,076)						—						(8,076)						(35,444)						—						(35,444)
Investing activities:
Purchases of property and equipment			(201)						—						(201)						(100)						—						(100)
Net cash used in investing activities			(201)						—						(201)						(100)						—						(100)
Financing activities:
Proceeds from underwritten public offering, net of issuance costs			17,256						—						17,256						—						—						—
Proceeds from public offering of common stock, net of issuance costs			8,706						—						8,706						500						—						500
Proceeds from exercise of stock options			14						—						14						—						—						—
Principal repayments of Term Loan			—						—						—						(2,222)						—						(2,222)
Net cash provided by (used in) financing activities			25,976						—						25,976						(1,722)						—						(1,722)
Net increase (decrease) in cash and cash equivalents			17,699						—						17,699						(37,266)						—						(37,266)
Cash and cash equivalents at beginning of period			32,731						—						32,731						62,273						—						62,273
Cash and cash equivalents at end of period			$	50,430					$	—					$	50,430					$	25,007					$	—					$	25,007
Supplemental disclosure of cash flows:
Interest paid			$	—					$	—					$	—					$	38					$	—					$	38
Income taxes paid			$	588					$	—					$	588					$	—					$	—					$	—
Non-cash investing activity:
Operating lease right-of-use asset obtained in exchange for lease liability			$	3,847					$	—					$	3,847					$	—					$	—					$	—
Non-cash financing activities:
Purchase of shares pursuant to Employee Stock Purchase Plan			$	63					$	—					$	63					$	69					$	—					$	69
Issuance costs incurred but not yet paid, included in accounts payable and accrued liabilities			$	—					$	—					$	—					$	720					$	—					$	720

			Nine Months Ended September 30, 2023																		Nine Months Ended September 30, 2022
Corrected Condensed Consolidated Statement of Cash Flows (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Operating activities:
Net loss			$	(17,320)					$	(2,398)					$	(19,718)					$	(16,422)					$	(3,565)					$	(19,987)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation			2,231						—						2,231						2,859						—						2,859
Non-cash operating lease expense			921						(26)						895						796						(72)						724
Depreciation and amortization			79						—						79						114						—						114
Amortization of costs to obtain a contract with a customer			53						—						53						1,772						—						1,772
Non-cash interest expense			—						—						—						1						—						1
Changes in assets and liabilities:
Accounts receivable			2,978						(323)						2,655						314						—						314
Inventory			(2,467)						(434)						(2,901)						—						—						—
Prepaid expenses, other current assets, and other assets			2,776						—						2,776						(1,662)						—						(1,662)
Accounts payable and accrued liabilities			6,204						—						6,204						(1,037)						—						(1,037)
Accrued indirect tax liabilities			—						3,155						3,155						—						3,725						3,725
Accrued compensation and benefits			(402)						—						(402)						(670)						—						(670)
Contract liabilities			(3,956)						—						(3,956)						7,314						(160)						7,154
Operating lease liabilities			(807)						26						(781)						(850)						72						(778)
Net cash used in operating activities			(9,710)						—						(9,710)						(7,471)						—						(7,471)
Investing activities:
Purchases of property and equipment			(327)						—						(327)						(109)						—						(109)
Net cash used in investing activities			(327)						—						(327)						(109)						—						(109)
Financing activities:
Proceeds from underwritten public offering, net of issuance costs			17,256						—						17,256						—						—						—
Proceeds from public offering of common stock, net of issuance costs			8,706						—						8,706						1,698						—						1,698
Proceeds from exercise of stock options			14						—						14						—						—						—
Issuance costs for underwritten public offering			—						—						—						(720)						—						(720)
Principal repayments of Term Loan			—						—						—						(2,593)						—						(2,593)
Net cash provided by (used in) financing activities			25,976						—						25,976						(1,615)						—						(1,615)
Net increase (decrease) in cash and cash equivalents			15,939						—						15,939						(9,195)						—						(9,195)
Cash and cash equivalents at beginning of period			32,731						—						32,731						62,273						—						62,273
Cash and cash equivalents at end of period			$	48,670					$	—					$	48,670					$	53,078					$	—					$	53,078

			Nine Months Ended September 30, 2023																		Nine Months Ended September 30, 2022
Corrected Condensed Consolidated Statement of Cash Flows (unaudited)			As Previously Reported						Restatement Adjustment						As Restated						As Previously Reported						Restatement Adjustment						As Restated
Supplemental disclosure of cash flows:
Interest paid			$	—					$	—					$	—					$	40					$	—					$	40
Income taxes paid			$	651					$	—					$	651					$	—					$	—					$	—
Non-cash investing activity:
Purchases of property and equipment, included in accounts payable and accrued liabilities			$	178					$	—					$	178					$	—					$	—					$	—
Operating lease right-of-use asset obtained in exchange for lease liability			$	3,847					$	—					$	3,847					$	—					$	—					$	—
Non-cash financing activities:
Purchase of shares pursuant to Employee Stock Purchase Plan			$	63					$	—					$	63					$	69					$	—					$	69
Proceeds from public offering of common stock, net of issuance costs, included in prepaid expenses, other current assets, and other assets			$	—					$	—					$	—					$	10					$	—					$	10

X

- References

No definition available.

+ Details

Name:	us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482964/270-10-50-1B

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 270
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org//270/tableOfContent

+ Details

Name:	us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration